Springdale, ARNCT05987241Now EnrollingIRB Ready

Urothelial Cancer Clinical Trial in Springdale, AR

Access cutting-edge urothelial cancer treatment through this clinical trial at a research site in Springdale. Study-provided care at no cost to qualified participants.

Sponsored by National Cancer Institute (NCI)

Quick Self-Assessment

See if you qualify for this Springdale location

Preparing your pre-screening questions...

Expert Care in Springdale

Access urothelial cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related urothelial cancer treatment provided free

Apply for This Springdale Location

Check if you qualify for this urothelial cancer clinical trial in Springdale, AR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Springdale

    Convenient for AR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Springdale site if eligible
  4. 4Begin participation

About This Urothelial Cancer Study in Springdale

This phase II/III trial examines whether patients who have undergone surgical removal of bladder, kidney, ureter or urethra, but require an additional treatment called immunotherapy to help prevent their urinary tract (urothelial) cancer from coming back, can be identified by a blood test. Many types of tumors tend to lose cells or release different types of cellular products including their DNA which is referred to as circulating tumor DNA (ctDNA) into the bloodstream before changes can be seen

Sponsor: National Cancer Institute (NCI)

Who Can Participate

Inclusion Criteria

PRE-REGISTRATION: Histologically confirmed muscle-invasive urothelial carcinoma of the urethra, bladder, ureter or renal pelvis
PRE-REGISTRATION: Variant histology, including neuroendocrine differentiation, sarcomatoid, micropapillary, glandular, trophoblastic, Mullerian, is allowed if urothelial cancer is predominant histology (any amount of squamous differentiation is allowed provided the tumor is not a pure squamous cell cancer)
PRE-REGISTRATION: Patient must have had radical surgery (i.e., cystectomy and lymph node dissection or nephroureterectomy or ureterectomy) ≥ 3 weeks, but ≤ 12 weeks prior to pre-registration. Patients who have had a partial cystectomy as definitive therapy are not eligible
PRE-REGISTRATION: No gross cancer at the surgical margins. Microscopic invasive urothelial carcinoma at the surgical margins (i.e., "positive margins") are allowed. Carcinoma in situ (CIS) at margins is considered negative margins
PRE-REGISTRATION: No evidenc

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Springdale?

Yes, this clinical trial (NCT05987241) has an active research site in Springdale, AR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Urothelial Cancer Treatment Options in Springdale, AR

If you're searching for urothelial cancer treatment options in Springdale, AR, this clinical trial (NCT05987241) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Springdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced urothelial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all urothelial cancer clinical trials near you to find additional studies recruiting in your area.

More Bladder Cancer Trials in Springdale, AR

See all bladder cancer clinical trials recruiting in Springdale — not just this study.

Browse Bladder Cancer Trials in Springdale →

Browse More Trials by Condition

Bladder Cancer TrialsAll Conditions →

Ready to Join in Springdale?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Springdale, AR